Pharmacopoeial impurityPhenylbutyrate EP Impurity ACat. No. P-P092-002CAS 2051-95-8Family · Pharmaceutical analytical standards
Phenylbutyrate
An aromatic fatty acid, used as its sodium salt and approved in the United States in 1996 for urea cycle disorders: in the body it becomes phenylacetate, which binds the nitrogen of glutamine and has it excreted in the urine instead of urea. This family brings together pharmacopoeial impurities, labelled standards and other impurities.
Did you know?The alternative nitrogen disposal pathway was discovered in the early 1980s at Johns Hopkins by Saul Brusilow and Mark Batshaw: phenylbutyrate replaced phenylacetate because, unlike it, it lacks an unpleasant smell.
Pharmacopoeial impurityPhenylbutyrate EP Impurity ACat. No. P-P092-002CAS 2051-95-8
Pharmacopoeial impurityPhenylbutyrate EP Impurity BCat. No. P-P092-003CAS 529-34-0
Pharmacopoeial impurityPhenylbutyrate EP Impurity CCat. No. P-P092-004CAS 4441-63-8
Isotopically labelledPhenylbutyrate-d11 Sodium SaltCat. No. P-P092-005CAS 1392208-11-5
ImpuritySodium PhenylbutyrateCat. No. P-P092-006CAS 1716-12-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceSodium phenylbutyrate CRSEDQM code Y0000808Family PhenylbutyrateImpuritySodium phenylbutyrate impurity C CRSEDQM code Y0000809Family PhenylbutyrateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.